Alaunos Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Alaunos Therapeutics, Inc. (TCRT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 506.00 thousand shares for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2018-11-09
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-09-30 was 300.50K shares, a 221.39% increase year-over-year.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-06-30 was 198.00K shares, a 33.33% increase year-over-year.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-03-31 was 7.50K shares, a 93.59% decline year-over-year.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2017-09-30 was 93.50K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month |
|---|---|---|---|
| 2018-09-30 | 300.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | 498.50K shares derived: sum of 2 quarters · filed 2018-11-09 | 506.00K shares 10-Q · filed 2018-11-09 |
| 2018-06-30 | 198.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 205.50K shares 10-Q · filed 2018-08-08 | |
| 2018-03-31 | 7.50K shares 10-Q · filed 2018-05-10 | ||
| 2017-09-30 | 93.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | 242.00K shares derived: sum of 2 quarters · filed 2017-11-06 | 359.00K shares 10-Q · filed 2017-11-06 |
| 2017-06-30 | 148.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | 265.50K shares 10-Q · filed 2017-07-31 | |
| 2017-03-31 | 117.00K shares 10-Q · filed 2017-05-01 | ||
| 2016-09-30 | 157.30K shares 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |